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Jean-Daniel Chiche1,2,3, Alain Cariou1,2, Jean-Paul Mira1,2,3 and Frédéric Pène1,2,3*Abstract
Background: Most studies about septic shock report a crude mortality rate that neither distinguishes between early
and late deaths nor addresses the direct causes of death. We herein aimed to determine the modalities of death in
septic shock.
Methods: This was a 6-year (2008–2013) monocenter retrospective study. All consecutive patients diagnosed for septic
shock within the first 48 h of intensive care unit (ICU) admission were included. Early and late deaths were
defined as occurring within or after 3 days following ICU admission, respectively. The main cause of death in the
ICU was determined from medical files. A multinomial logistic regression analysis using the status alive as the
reference category was performed to identify the prognostic factors associated with early and late deaths.
Results: Five hundred forty-three patients were included, with a mean age of 66 ± 15 years and a high proportion
(67 %) of comorbidities. The in-ICU and in-hospital mortality rates were 37.2 and 45 %, respectively. Deaths occurred
early for 78 (32 %) and later on for 166 (68 %) patients in the ICU (n = 124) or in the hospital (n = 42). Early deaths were
mainly attributable to intractable multiple organ failure related to the primary infection (82 %) and to mesenteric
ischemia (6.4 %). In-ICU late deaths were directly related to end-of-life decisions in 29 % of patients and otherwise
mostly related to ICU-acquired complications, including nosocomial infections (20.4 %) and mesenteric ischemia
(16.6 %). Independent determinants of early death were age, malignancy, diabetes mellitus, no pathogen identification,
and initial severity. Among 3-day survivors, independent risk factors for late death were age, cirrhosis, no pathogen
identification, and previous corticosteroid treatment.
Conclusions: Our study provides a comprehensive assessment of septic shock-related deaths. Identification of risk
factors of early and late deaths may determine differential prognostic patterns.Background
The incidence of sepsis is increasing as a result of popu-
lation’s aging and associated comorbidities such as can-
cer, immunosuppression, diabetes mellitus, or chronic
organ dysfunctions. Although the higher number of
cases accounted for an overall increase in sepsis-related
deaths, the attributable fatality rate significantly dropped
at the turn of the century. About 20 years ago, the crude
mortality rate of septic shock exceeded 50 % in non-
selected populations [1, 2]. Since then, improvement in
management of severe sepsis and septic shock trans-
lated into increased survival rate in observational stud-
ies [3–8]. This is also emphasized by the low mortality* Correspondence: frederic.pene@cch.aphp.fr
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provided the original work is properly creditedrates ranging from 24.2 to 32 % observed in the control
arms of recent interventional studies on severe sepsis
and septic shock [9–11].
While the literature is plenty of studies with vital sta-
tus as the main outcome, it is striking that very few data
are available about the time to death and the causes that
ultimately led to death in septic patients. Nowadays, the
combination of anti-infective treatments and aggressive
organ failure supports often allows stabilization of the
clinical condition, but patients become then exposed to
intensive care unit (ICU)-acquired complications that
significantly impact on the prognosis. Nevertheless, most
epidemiological and interventional studies about septic
shock report crude mortality rates that make deaths dir-
ectly related to the initial septic process or to secondary
nosocomial infections hardly distinguishable. The nega-
tive results of interventional studies in sepsis despite a
robust scientific rationale should then question aboutrticle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
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septic patients. Lastly, a number of ICU patients die
after therapeutic limitations as a result of withholding or
withdrawing life support decisions that were not accur-
ately reported within studies. With respect to the
current trends in epidemiology and outcome of septic
shock and to the design of future interventional trials in
the field, a better comprehension of the clinical course
of septic shock is required beyond the common but
gross endpoint of vital status. To this aim, we performed
a retrospective study aimed at studying the timing and
related causes of death in this setting, as well as respect-
ive predictors of early and late deaths.
Methods
Patients and setting
The study took place in a 24-bed tertiary medical ICU
with an average of 1600 admissions per year. From Janu-
ary 2008 to July 2013, all adult patients (age ≥18 years
old) diagnosed with septic shock within the first 48 h of
ICU admission were included. Septic shock was defined
by the association of the following: (i) a suspected or
proven infection, (ii) at least two criteria of systemic in-
flammatory response syndrome, (iii) an acute circulatory
failure requiring vasopressor support. There were no ex-
clusion criteria other than age below 18 years old. Septic
shock was defined as a microbiologically proven or clin-
ically suspected infection, associated with acute circula-
tory failure requiring vasopressors despite adequate fluid
filling [12]. Senior staffing remained stable over the 6-
year study period. End-of-life decisions to withhold or
withdraw life support were taken on collectively when
maintenance or increase of life-sustaining therapies was
considered as futile by all participants and that death
would irremediably occur in a short-term manner. This
procedure is standardized in our unit. Data were com-
puted from medical files and extracted from the patient
data management system (Clinisoft, GE Healthcare).
The ethics committee of the French Intensive Care Soci-
ety (Société de Réanimation de Langue Française, CE
SRLF #12-402) approved the protocol and waived pa-
tient’s consent.
Intended care for patients with septic shock
Patients were promptly treated with broad-spectrum
antibiotic combination, depending on the site of infection,
previous antibiotic treatment, and known colonization
with multidrug-resistant bacteria. Antimicrobial treatment
was deescalated to narrower spectrum after identification
of the responsible pathogen. Source control measures,
such as surgery or removal of infected devices, were ap-
plied when necessary. Besides, patients were treated ac-
cording to the 2008 guidelines of the Surviving Sepsis
Campaign [13]. Renal replacement therapy was commonlyindicated in established acute renal failure but was also
performed early in the course of septic shock in case of
profound metabolic acidosis.
Collection of data
For each patient, the following data were collected: demo-
graphics (age and gender), comorbidities, malignancy
under treatment within the year prior to ICU admission.
Features of immunosuppression included intravenous
chemotherapy during the last 3 months, leuconeutropenia
defined by leucocyte count <1000/mm3 and/or neutrophil
count <500/mm3, HIV infection at any stage, treatment
with corticosteroids for more than 3 months at any dos-
age, or ≥0.5 mg/kg prednisone equivalent per day for
more than 7 days, and treatment with other immunosup-
pressive drugs.
Characteristics of the primary infection were described
as follows: community- or healthcare-acquired, source of
infection, bacteremia, causing pathogen. The adequacy
of initial antibiotic treatment was assessed in microbio-
logically documented infections and was defined as at
least one antimicrobial active against the pathogen. Se-
verity at admission was assessed by Simplified Acute
Physiology Score II (SAPS II) and Sequential Organ Fail-
ure Assessment (SOFA) scores during the first 24 h of
ICU admission [14, 15].
Characteristics of deaths
The modalities of death were investigated by collecting
the date, the location (in-ICU and in-hospital), and the
main cause of death. Early and late deaths were a priori
defined as occurring within or after 3 days following
ICU admission, respectively. This was based on previous
works performed in non-cancer critically ill patients and
cancer patients with septic shock, for whom trends in
organ failures during the first 3 days in the ICU were
found accurate predictors of outcome as compared to
single assessment on admission [16–18, 8]. Hence, it is
our usual policy of full engagement for a 3-day time
frame for most septic patients. Allocation of the cause of
death was aimed to identify the disease responsible for
fatality rather than the final common pathways of ter-
minal organ failures. Disorders responsible for death
were determined by analysis of the medical file by two
independent physicians (FD and DG), and discrepancies
were resolved by consensus. ICU-acquired infections
were defined as new infections acquired more than 48 h
after ICU admission. Decisions to withholding or with-
drawing life support were also collected. Mesenteric is-
chemia was proven by macroscopic exam during surgery
or by digestive endoscopy or was strongly suspected on
the basis of clinical symptoms, elevated arterial blood
lactate, and/or biological evidence of acute cell lysis (ele-
vated serum levels of lactate dehydrogenase, creatine
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gestive abdominal CT scan findings such as lack of
contrast enhancement of the bowel, pneumatosis intes-
tinalis, and pneumatosis in the intra-hepatic portal
vein branches [19].
Statistical analysis
Continuous variables were expressed as mean ± SD or
median (interquartile range) and categorical variables as
numbers and percentages. The characteristics of patients
who died early (≤3 days from ICU admission), lately
(>3 days), or who survived were compared using chi-
square tests or Fisher exact tests as appropriate for cat-
egorical variables and ANOVA for continuous variables.
Factors independently associated with early or late in-
hospital death were identified using a multinomial logis-
tic regression model using the status alive as the refer-
ence category. Variables significantly associated with
early or late death in univariate analysis were included in
the model. Multicolinearity was checked by calculating
the variance inflation factor. A p < 0.05 was considered
statistically significant. Statistical analyses were per-
formed using SAS version 9.3.
Results
Patients’ characteristics
During the study period, 543 patients presented with
septic shock during the first 48 h following ICU admis-
sion (Fig. 1 and Table 1). Sixty-seven percent of patients
had underlying comorbidities and 40 % were immuno-
compromised. Healthcare-associated infections accounted
for 53 % of septic episodes. The main site of primary in-
fection was the lung (53 % of patients). A causing patho-
gen was identified in 69 % of patients. With respect to
organ failure supports, invasive mechanical ventilation
and renal replacement therapy were required in 88 and
51 % of patients, respectively.Fig. 1 Flow chart of the study. Percentages were computed from the studTiming and causes of deaths
The in-ICU and in-hospital mortality rates were 37.2
and 45 %, respectively, and remained consistent over
the study period. Among 244 patients deceased in the
hospital, 78 (32 %) died within the first 3 days of ICU
admission (early deaths) and 166 (68 %) died there-
after (late deaths) in the ICU (n = 124) or in the hos-
pital (n = 42) (Fig. 2).
We investigated the primary disorders directly respon-
sible for death in septic patients. With respect to the 42
patients who died after ICU discharge, a comprehensive
assessment of the primary cause of death could not be
reliably investigated from medical reports. Of note, only
six patients who had been transferred to their referent
hospital at ICU discharge were readmitted to the local
ICU and died there. Definite causes of early and late
deaths in the ICU are displayed in Fig. 3. End-of-life
decisions precipitated early death in two patients with
end-stage comorbidities and previous do-not-resuscitate
orders. Late deaths in the ICU also directly resulted
from end-of-life decisions in 36 (29 %) patients with
fixed multiple organ failure for whom the treating physi-
cians were convinced that meaningful recovery was not
possible. Therefore, extensive diagnostic procedures
were not carried out in such settings of exclusive pallia-
tive care. Besides, most early-onset deaths were directly
related to the primary infection through intractable
shock and multiple organ failure (82 % of early dece-
dents) (Fig. 3a). In addition, 6.4 % of early decedents
were diagnosed with mesenteric ischemia likely to act as
a consequence or a contributor of multiple organ failure.
Most late deaths were related to ICU-acquired complica-
tions such as nosocomial infections (20.4 %) and mesen-
teric ischemia (16.6 %) (Fig. 3b). Regardless of the time
to death, the diagnosis of mesenteric ischemia was
proven by surgery (42 %) or endoscopy (5 %) or relied
on highly suggestive CT scan findings (53 %).y cohort of 543 patients
Table 1 Characteristics of survivors and early (≤3 days) and late (>3 days) deceased
Variables All patients Alive Early deaths Late deaths p
n = 543 n = 299 n = 78 n = 166
Demographics
Age, years 66 ± 15 63 ± 16 70 ± 15 69 ± 13 <0.0001
Male gender 346 (64) 196 (66) 49 (63) 101 (61) 0.64
Comorbidities
Malignancy 139 (25) 61 (20) 32 (41) 46 (28) 0.0008
Chronic heart failure 126 (23) 59 (20) 18 (23) 49 (29) 0.06
Chronic pulmonary disease 103 (19) 47 (16) 15 (19) 41 (25) 0.06
Diabetes mellitus 96 (18) 46 (15) 22 (28) 28 (17) 0.03
Cirrhosis 65 (12) 28 (9) 9 (11) 28 (17) 0.06
Chronic kidney failure 60 (11) 29 (10) 8 (10) 23 (14) 0.38
Factors of immunosuppression
Chemotherapy during the last 3 months 64 (12) 33 (11) 13 (17) 18 (11) 0.36
Leuconeutropenia 41 (7) 21 (7) 13 (17) 7 (4) 0.002
Corticosteroid treatment 91 (17) 39 (13) 15 (19) 37 (22) 0.03
Other immunosuppressive drugs 46 (8) 19 (6) 8 (10) 19 (11) 0.14
HIV infection 6 (1) 4 (1) 0 (0) 2 (1) 0.86
Infection characteristics
Healthcare-related infections 286 (53) 148 (49) 44 (56) 94 (57) 0.26
Source of infection 0.003
Lung 286 (53) 146 (49) 43 (55) 97 (58)
Abdominal 91 (17) 40 (14) 15 (19) 36 (22)
Urinary tract 63 (12) 46 (15) 6 (8) 11 (7)
Catheter 18 (3) 15 (5) 1 (1) 2 (1)
Skin and soft tissue 33 (6) 22 (7) 2 (3) 9 (5)
Othersa 52 (9) 30 (10) 11 (14) 11 (7)
Microbiological documentation 376 (69) 221 (74) 48 (61) 107 (64) 0.03
Type of microorganismb 0.50
Gram-negative bacteria 206 (55) 127 (58) 26 (54) 53 (49)
Gram-positive bacteria 151 (40) 82 (37) 21 (44) 48 (44)
Othersc 19 (5) 11 (5) 1 (2) 7 (6)
Positive blood cultures 166 (30) 102 (34) 22 (28) 42 (25) 0.12
Admission biological findings
Leucocytes (G/L) 12.0 [5.6–18.7] 11.3 [6–18.4] 9.2 [1.7–25] 13 [6.7–18] 0.07
Arterial blood lactate (mmol/L) 2.9 [1.5–5.4] 2.2 [1.4–4] 7.8 [4.3–11.8] 2.7 [1.4–5.9] <0.0001
Creatininemia (μmol/L) 139 [88–215] 129 [82–186] 196 [127–281] 137 [85–214] 0.02
Prognostic scoring systems
Admission SOFA score 9 [6–12] 9 [5–12] 11 [9–14] 9 [5–12] 0.0005
Admission SAPS II 66 [51–85] 58 [46–80] 86 [77–101] 67 [53–83] <0.0001
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Table 1 Characteristics of survivors and early (≤3 days) and late (>3 days) deceased (Continued)
Organ failure supports
Mechanical ventilation 476 (88) 241 (81) 77 (99) 158 (95) <0.0001
Renal replacement therapy 277 (51) 101 (34) 65 (83) 111 (67) <0.0001
Stress-dose corticosteroids 250 (46) 111 (37) 58 (74) 81 (49) <0.0001
Categorical variables are expressed as numbers (percentages) and continuous variables as mean ± SD or median [interquartile range] as appropriate. Comparisons
were performed between the three subgroups (alive patients and early and late deceased)
HIV human immunodeficiency virus, SOFA Sequential Organ Failure Assessment, SAPS Simplified Acute Physiology Score
aMeningitis (n = 7), bone and joint (n = 7), endocarditis (n = 5), gynecological (n = 4), mediastinitis (n = 3), head and neck (n = 2), unknown (n = 24)
bPercentages are computed from patients with microbiological documentation
cFungi (n = 8), virus (n = 9), mycobacteria (n = 2)
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We investigated the determinants of mortality with re-
spect to the timing of death by comparing the character-
istics of patients who survived or died either early or
lately (Table 1). In addition, most patients (93 %) with
microbiologically documented infections received ad-
equate initial antimicrobial treatment, without any dif-
ference among survivors and early and late decedents
(94, 87, and 91 %, respectively, p = 0.19). In multivariate
analysis, increasing age, diabetes mellitus, malignancy,
lack of pathogen identification, and higher admission SOFA
score remained independent risk factors of early death.
Among patients who survived the first 3 days, independent
determinants of late death included increasing age, cirrho-
sis, lack of pathogen identification, and previous cortico-
steroid treatment (Fig. 4). When entered into the model,
neither chronic pulmonary disease nor chronic heart failure
was associated with early or late death (data not shown).
Discussion
The crude mortality rate is commonly used as the main
criterion of outcome in septic shock, but it is clearly lim-
ited to assess the prognosis with respect to the clinical
diversity of the disorder. Although the visual aspects of
survival curves from retrospective or prospective studies
provide a gross evaluation of death kinetics in the course
of septic shock, specific and reliable data about theFig. 2 Distribution of deaths according to time from ICU admission. Numb
week thereafter. Early (≤3 days) and late (>3 days) deaths occurred in 78 (3timing of deaths are scarce. We herein provided an original
comprehensive analysis of modalities of death in septic
shock. Because obtaining an accurate etiological diagnosis
is of paramount importance in the outcome of critically ill
patients, we aimed at describing the primary cause of death
as a disease and not as accumulation of organ failures. With
respect to the high prevalence of comorbidities and high se-
verity scores on admission, the in-hospital mortality rate of
septic shock was 45 % in the present unselected cohort.
This is in line with the in-hospital mortality rate of 48.6 %
in a recent French cohort of septic shock with similar fea-
tures, including a similar prevalence of comorbidities
(65 %) [5]. The current mortality rate of the ANZICS co-
hort was reported seemingly lower (22 %), but it encom-
passed both severe sepsis and septic shock, and the
prevalence of comorbidities was only 35 % [4].
The extent of multiple organ failure accounted for the
large majority of early deaths in the present cohort.
However, the 3-day mortality rate was only 14.3 %, com-
pared to the 3-day mortality rate of 27 % in a cohort of
septic shock patients managed in the ICU during the
early 1990s [20]. Two French and Spanish multicenter
observational studies that included both severe sepsis
and septic shock patients in 2001–2002 reported consist-
ent mortality rates of 13.3 and 14.8 %, respectively [21,
22]. Altogether, these data suggest that the overall im-
provement in the outcome of septic shock is at leasters of deaths are represented per day during the first 2 weeks and per
2 %) and 166 (68 %) patients, respectively
Fig. 3 Definite causes of early (a, n = 78) and late (b, n = 124) deaths in the ICU. Others (one asterisk): myocardial infarction (n = 1), pulmonary
embolism (n = 1), ARDS-related refractory hypoxemia (n = 1), intestinal obstruction (n = 1). Iatrogenic complications (two asterisks): hypoxemic cardiac
arrest complicating emergency endotracheal intubation (n = 3). Digestive complications (three asterisks): gastrointestinal hemorrhage (n = 2), digestive
perforation (n = 3). Others (four asterisks): myocardial infarction (n = 2), lymphoma-related tumor lysis syndrome (n = 2), extensive limb ischemia (n = 1),
acute liver failure (n = 1). Iatrogenic complications (five asterisks) related to chest tube insertion (n = 1), catheter insertion (n = 1), accidental removal of
tracheostomy (n = 1), and cardiac arrest at the start of hemodialysis (n = 1). MOF multiple organ failure, ICU intensive care unit, ARDS acute respiratory
distress syndrome
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is likely that the Surviving Sepsis Campaign bundles for
early and aggressive resuscitation of severe sepsis and
septic shock contributed to decrease the number of early
deaths [23, 13]. Interestingly, admission SOFA scores
were similar between alive and late deceased patients,suggesting that late deaths were less related to the initial
severity, and were rather dependent on subsequent de-
velopment of lethal ICU-acquired complications and/or
therapeutic limitations. Beyond the classical paradigm of
sepsis where overwhelming inflammation is responsible
for lethal multiple organ failure, the development of
Fig. 4 Prognostic factors of early- (≤3 days) and late-onset (>3 days) mortality. Results of the multivariate multinomial logistic regression analysis. All
variables entered into the model are displayed on the figure. The variance inflation factor was less than or around 1 for all variables that denotes a low
risk of colinearity
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vive the primary insult may favor the development of
secondary infections in addition to other common risk
factors related to severity and requirements for invasive
procedures [24–26]. Ventilator-associated pneumonia
remains the most dreaded infectious complication in
critically ill patients. Although its attributable mortality
remains a matter of debate, it is clearly associated with
increased duration of mechanical ventilation and in-
creased length of stay in the ICU [27–29].
The identification of mesenteric ischemia as a frequent
cause of death both in early and late phases of septic
shock is an interesting finding. ICU-acquired mesenteric
ischemia is most often associated with microvascular ab-
normalities. Non-occlusive mesenteric ischemia is a
common complication of shock regardless of the under-
lying etiology and is often considered as the main con-
tributor to terminal multiple organ failure in relation
with breaches in the digestive mucosal barrier [30]. Thus,
mesenteric ischemia might reflect the severity of shock,
and individualizing it as an alternative or independentcause of death is debatable. Yet, the diagnosis is often dif-
ficult and is based on the combination of clinical manifes-
tations, biological markers of cell lysis, and suggestive
abdominal CT scan findings. A definite diagnosis might be
confirmed by digestive endoscopic examination, even up
to exploratory laparotomy when highly suspected. In a re-
cent multicenter study of 780 critically ill patients with
mesenteric ischemia, the diagnosis was based on CT scan
findings in 58 % of patients while it could be proven by
surgery and digestive endoscopy in 27 and 15 % of pa-
tients, respectively. The outcome was poor as assessed by
a mortality rate of 58 % and was dependent on severity
but also on the possibility of surgical treatment [19].
Most interestingly, the underlying comorbidities and
especially the patterns of immunodeficiency determined
differential prognostic patterns in patients with septic
shock [31]. Cancer was a predictor of early death, pre-
sumably related in part to leuconeutropenia imposed by
chemotherapy or bone marrow infiltration. Neutropenia
is a major risk factor for fulminant sepsis. In addition,
neutropenic sepsis is often associated with non-infectious
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[32]. Diabetic patients are often affected by chronic organ
dysfunctions likely to affect their response to aggression
[33]. Altogether, these results highlight the pejorative im-
pact of quantitative or functional defective phagocytosis
on early outcome of septic shock. In contrast, patients
with previous corticosteroid treatment seemed relatively
preserved from early mortality but were more likely to die
later. This finding is intriguing but could be related to the
impact of corticosteroids on maintenance of vascular re-
sponse to vasopressors or immunomodulatory properties
toward the overwhelming inflammatory response of septic
shock [34–36]. Cirrhosis is well known to be associated
with a high mortality rate in case of septic shock and was
rather found to be associated with late mortality. Aggres-
sive management of septic shock clearly resulted in im-
proved early survival in cirrhotic patients, who then
become exposed to secondary infectious and non-
infectious complications [37, 38].
This study has several limitations. The major limit cer-
tainly lies in the retrospective design of the study. How-
ever, we included all consecutive patients within the
study period, and the collection of data was almost ex-
haustive. The characteristics of our cohort, such as the
high prevalence (40 %) of immunosuppression, were
highly dependent on our hospital environment compris-
ing large departments of oncology, hematology, and in-
ternal medicine, and our findings may not fully apply to
other centers. In the same way, most patients are admit-
ted to our unit for medical reasons, which limits the
generalization to surgical patients. The cut-off between
early (≤3 days) and late (>3 days) deaths is debatable but
is relevant for refining the prognostic assessment of crit-
ically ill patients with septic shock [18, 8]. Furthermore,
it allows comparability to previous observational studies
[20–22]. In the present study, the distribution of deaths
over time clearly exhibited a high mortality rate over the
first 3 days, suggesting that this time frame is clinically
relevant. We reported the seemingly primary cause of
death unambiguously diagnosed at the bedside, but we
cannot rule out that some additional disorders might
have contributed to the lethal process in such complex
clinical settings. A number of patients died in the ICU
as a result of end-of-life decisions and therefore did not
undergo exhaustive diagnostic procedures. In addition,
the primary cause of death of patients deceased after
ICU discharge could not be reliably addressed. However,
the low rate of ICU readmission (6 out of 42) suggests
that most patients had been subjected to therapeutic
limitations in the wards. Finally, autopsy was rarely per-
formed in the present cohort because of logistic limita-
tions in our hospital. A number of studies have
emphasized that autopsy findings substantially contrib-
uted to the diagnosis of critically ill patients [39, 40].Specifically, an autopsic study in patients who died from
sepsis has revealed continuous septic foci that may have
contributed to multiple organ failure and death [41].Conclusions
We herein provided a comprehensive assessment of sep-
tic shock-related deaths. It clearly identifies subgroups of
patients with different prognostic patterns in the ICU.
Our findings carry several potential implications includ-
ing early identification of high-risk patients that would
require early and aggressive management in the ICU, as
well as prevention and detection of secondary complica-
tions. In addition, the risk stratification of early or late
deaths may also impact on the design and the thera-
peutic goals of future interventional studies in septic
shock.
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